Position in ANIP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,183,257
+$140,801 QoQ
Shares Held
14,294
+5.4% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#137
of 305 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 11%
Shared 89%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VIRTUS ADVISERS, LLC holds $9,867,527 across 13 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
49,354 | $2,586,149 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
107,110 | $1,552,023 | |
| 3 | PAHC |
Phibro Animal Health Corp
|
43,092 | $1,353,088 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
This page
|
14,294 | $1,183,257 | |
| 5 | LQDA |
Liquidia Corp
|
8,680 | $692,055 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
36,823 | $637,406 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
2,714 | $457,417 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
315,737 | $359,940 |
All Filings in ANIP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,183,257 | 14,294 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $1,042,456 | 13,556 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $1,255,618 | 15,906 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,456,989 | 15,906 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $1,037,865 | 15,906 | Shares | Other | 2026-02-13 | |
| 2025-03-31 | $921,967 | 13,771 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||